| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Receptos Inc | 25,679 | 4,234,000 | 3.55% | ||
| 2 | CLOVIS ONCOLOGY INC | 55,988 | 4,156,000 | 3.48% | ||
| 3 | SALIX PHARMACEUTICALS INC | 24,000 | 4,147,000 | 3.48% | ||
| 4 | BIOMARIN | 32,545 | 4,056,000 | 3.40% | ||
| 5 | INCYTE | 43,682 | 4,004,000 | 3.36% | ||
| 6 | MEDIVATION INC | 30,747 | 3,969,000 | 3.33% | ||
| 7 | REGENERON PHARMACEUTICALS | 8,750 | 3,950,000 | 3.31% | ||
| 8 | BIOGEN INC | 9,331 | 3,940,000 | 3.30% | ||
| 9 | SEATTLE GENETICS INC | 111,050 | 3,926,000 | 3.29% | ||
| 10 | ALNYLAM PHARMACEUTICALS INC | 37,388 | 3,904,000 | 3.27% | ||
| 11 | IONIS PHARMACEUTICAL | 60,912 | 3,878,000 | 3.25% | ||
| 12 | VERTEX PHARMACEUT | 32,805 | 3,870,000 | 3.24% | ||
| 13 | CELGENE CORP | 33,289 | 3,838,000 | 3.22% | ||
| 14 | ILLUMINA INC | 20,609 | 3,826,000 | 3.21% | ||
| 15 | ALEXION PHARMACEUTIC | 22,031 | 3,818,000 | 3.20% | ||
| 16 | ALKERMES PLC SHS | 62,546 | 3,813,000 | 3.20% | ||
| 17 | NEKTAR THERAPEUTICS COM | 335,650 | 3,692,000 | 3.09% | ||
| 18 | PHARMACYCLICS INC | 13,600 | 3,481,000 | 2.92% | ||
| 19 | CEPHEID | 54,693 | 3,112,000 | 2.61% | ||
| 20 | PACIRA BIOSCIENCES INC | 34,949 | 3,105,000 | 2.60% | ||
| 21 | METTLER-TOLEDO | 9,436 | 3,101,000 | 2.60% | ||
| 22 | BIO TECHNE CORP | 30,917 | 3,101,000 | 2.60% | ||
| 23 | QIAGEN NV | 122,724 | 3,093,000 | 2.59% | ||
| 24 | PROSHARES TR | 17,784 | 2,817,000 | 2.36% | ||
| 25 | SYNAGEVA BIOPHARMA CORP | 17,700 | 1,726,000 | 1.45% | ||
| 26 | HOLOGIC INC | 50,000 | 1,651,000 | 1.38% | ||
| 27 | ARRAY BIOPHARMA INC COM | 200,000 | 1,474,000 | 1.24% | ||
| 28 | Esperion Therapeutics Inc | 15,000 | 1,389,000 | 1.16% | ||
| 29 | VERICEL CORP | 362,157 | 1,340,000 | 1.12% | ||
| 30 | TESARO INC | 20,000 | 1,148,000 | 0.96% | ||
| 31 | STEMLINE THERAPEUTICS INC | 75,000 | 1,085,000 | 0.91% | ||
| 32 | XENOPORT INC | 130,000 | 926,000 | 0.78% | ||
| 33 | Momenta Pharmaceuticals Inc | 60,000 | 912,000 | 0.76% | ||
| 34 | EPIZYME INC COM | 48,339 | 908,000 | 0.76% | ||
| 35 | UNITED THERAPEUTICS | 5,213 | 899,000 | 0.75% | ||
| 36 | ASSEMBLY BIOSCIENCES INC | 65,000 | 861,000 | 0.72% | ||
| 37 | OCERA THERAPEUTICS INC | 182,673 | 860,000 | 0.72% | ||
| 38 | SANOFI SPOND FUNSPONSORED ADR | 72,009 | 855,000 | 0.72% | ||
| 39 | TENAX THERAPEUTICS INC COM | 249,004 | 812,000 | 0.68% | ||
| 40 | CELLADON CORP | 42,414 | 803,000 | 0.67% | ||
| 41 | AMGEN INC | 4,938 | 789,000 | 0.66% | ||
| 42 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 41,788 | 751,000 | 0.63% | ||
| 43 | ULTRAGENYX PHARMACEUTICAL INC COM | 12,000 | 745,000 | 0.62% | ||
| 44 | MIRATI THERAPEUTICS INC COM | 25,000 | 733,000 | 0.61% | ||
| 45 | BLUEBIRD BIO INCORPORATED | 6,000 | 725,000 | 0.61% | ||
| 46 | CHIMERIX INC | 19,152 | 722,000 | 0.61% | ||
| 47 | XENCOR INC COM | 44,698 | 685,000 | 0.57% | ||
| 48 | ACHILLION PHARMACEUTICALS INC COM | 66,704 | 658,000 | 0.55% | ||
| 49 | RELYPSA INC | 18,000 | 649,000 | 0.54% | ||
| 50 | AERIE PHARMACEUTICALS INC | 20,000 | 627,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-001782, filed 2015.05.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
